Material and methods for treating or preventing HER-3 associated diseases

Details for Australian Patent Application No. 2010319483 (hide)

Owner U3 Pharma GmbH Amgen

Inventors Hettmann, Thore; Freeman, Daniel J.; Radinsky, Robert

Agent Pizzeys

Pub. Number AU-A-2010319483

PCT Pub. Number WO2011/060206

Priority 61/261,149 13.11.09 US

Filing date 12 November 2010

Wipo publication date 19 May 2011

International Classifications

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/30 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/32 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

31 May 2012 PCT application entered the National Phase

  PCT publication WO2011/060206 Priority application(s): WO2011/060206

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010319484-Use of powder-coated nickel foam as a resistor to increase the temperature of catalytic converter devices with the use of electricity

2010319481-Ventilation systems and methods